AINewsnow

PSIL-AD 2026: Building an AI-Native Clinical Trial for Alzheimer’s Disease

This story is from 2026-08-30. It is preserved in the archive; the latest stories are on the live feed.

What if the next breakthrough in Alzheimer’s research isn't a new biomarker or a new drug—but an AI system capable of understanding which brain, biological, and behavioral states are most likely to respond to an intervention? That is the idea behind PSIL-AD 2026 . Rather than designing another conv…

Read the full story at DEV Community — AI ↗

Timeline · 1 report

  1. 2026-08-30 02:24 · DEV Community — AI
    PSIL-AD 2026: Building an AI-Native Clinical Trial for Alzheimer’s Disease

More stories

  1. Introducing Kimi K3 on Amazon Bedrock — AWS Machine Learning Blog
  2. Introducing Amazon SageMaker HyperPod Inference Gateway — AWS Machine Learning Blog
  3. Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
  4. Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
  5. NVIDIA CEO Jensen Huang rejects ‘AI will end the world’ claim, yet cautions ‘we should go as fast as we can but...’ — Mint AI
  6. AI hallucination of Chinese nuclear components almost led to US military attack — Ars Technica AI
  7. The new AgentCore runtime: Elastic, optimized, and consistently fast starts — AWS Machine Learning Blog
  8. Qwen Image 2.1 PR to ComfyUI — r/StableDiffusion

Get the daily brief of stories like this at 6:30 every morning →